178 related articles for article (PubMed ID: 33781052)
1. Children's Hepatic Tumors International Collaboration-Hepatoblastoma Stratification (CHIC-HS) System for Pediatric Patients with Hepatoblastoma: A Retrospective, Hospital-Based Cohort Study in South Korea.
Kim PH; Shin HJ; Yoon HM; Choi YH; Namgoong JM; Kim DY; Koh KN; Lee MJ; Yoon H; Lyu CJ; Han JW; Hahn SM; Cho YA
Cancer Res Treat; 2022 Jan; 54(1):253-258. PubMed ID: 33781052
[TBL] [Abstract][Full Text] [Related]
2. Independent Assessment of the Children's Hepatic Tumors International Collaboration Risk Stratification for Hepatoblastoma and the Association of Tumor Histological Characteristics With Prognosis.
Zhou S; Malvar J; Chi YY; Stein J; Wang L; Genyk Y; Sposto R; Mascarenhas L
JAMA Netw Open; 2022 Feb; 5(2):e2148013. PubMed ID: 35147687
[TBL] [Abstract][Full Text] [Related]
3. Recent improvement in survival outcomes and reappraisal of prognostic factors in hepatoblastoma.
Koh KN; Namgoong JM; Yoon HM; Cho YA; Choi SH; Shin J; Kang SH; Suh JK; Kim H; Oh SH; Kim KM; Kim DY; Im HJ
Cancer Med; 2021 May; 10(10):3261-3273. PubMed ID: 33939313
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors for Event-Free Survival in Pediatric Patients with Hepatoblastoma Based on the 2017 PRETEXT and CHIC-HS Systems.
Yoon HM; Hwang J; Kim KW; Namgoong JM; Kim DY; Koh KN; Kim H; Cho YA
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540387
[TBL] [Abstract][Full Text] [Related]
5. A novel risk stratification model based on the Children's Hepatic Tumours International Collaboration-Hepatoblastoma Stratification and deoxyribonucleic acid methylation analysis for hepatoblastoma.
Kondo T; Honda S; Suzuki H; Ito YM; Kawakita I; Okumura K; Ara M; Minato M; Kitagawa N; Tanaka Y; Tanaka M; Shinkai M; Hishiki T; Watanabe K; Ida K; Takatori A; Hiyama E; Taketomi A
Eur J Cancer; 2022 Sep; 172():311-322. PubMed ID: 35816972
[TBL] [Abstract][Full Text] [Related]
6. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
Meyers RL; Maibach R; Hiyama E; Häberle B; Krailo M; Rangaswami A; Aronson DC; Malogolowkin MH; Perilongo G; von Schweinitz D; Ansari M; Lopez-Terrada D; Tanaka Y; Alaggio R; Leuschner I; Hishiki T; Schmid I; Watanabe K; Yoshimura K; Feng Y; Rinaldi E; Saraceno D; Derosa M; Czauderna P
Lancet Oncol; 2017 Jan; 18(1):122-131. PubMed ID: 27884679
[TBL] [Abstract][Full Text] [Related]
7. The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model.
Czauderna P; Haeberle B; Hiyama E; Rangaswami A; Krailo M; Maibach R; Rinaldi E; Feng Y; Aronson D; Malogolowkin M; Yoshimura K; Leuschner I; Lopez-Terrada D; Hishiki T; Perilongo G; von Schweinitz D; Schmid I; Watanabe K; Derosa M; Meyers R
Eur J Cancer; 2016 Jan; 52():92-101. PubMed ID: 26655560
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
[TBL] [Abstract][Full Text] [Related]
9. The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database.
Haeberle B; Rangaswami A; Krailo M; Czauderna P; Hiyama E; Maibach R; Lopez-Terrada D; Aronson DC; Alaggio R; Ansari M; Malogolowkin MH; Perilongo G; O'Neill AF; Trobaugh-Lotrario AD; Watanabe K; Schmid I; von Schweinitz D; Ranganathan S; Yoshimura K; Hishiki T; Tanaka Y; Piao J; Feng Y; Rinaldi E; Saraceno D; Derosa M; Meyers RL
Pediatr Blood Cancer; 2020 Aug; 67(8):e28350. PubMed ID: 32383794
[TBL] [Abstract][Full Text] [Related]
10. CHIC Risk Stratification System for Predicting the Survival of Children With Hepatoblastoma: Data From Children With Hepatoblastoma in China.
Huang J; Hu Y; Jiang H; Xu Y; Lu S; Sun F; Zhu J; Wang J; Sun X; Liu J; Zhen Z; Zhang Y
Front Oncol; 2020; 10():552079. PubMed ID: 33312943
[TBL] [Abstract][Full Text] [Related]
11. A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.
Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
BMC Cancer; 2021 Apr; 21(1):397. PubMed ID: 33849485
[TBL] [Abstract][Full Text] [Related]
12. Analysis of risk factors for angiolymphatic invasion and establishment of a predictive nomogram for hepatoblastomas.
Ke M; Zhou Y; Yang CZ; Li L; Diao M
J Pediatr Surg; 2022 Oct; 57(10):430-437. PubMed ID: 35365339
[TBL] [Abstract][Full Text] [Related]
13. Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.
Maibach R; Roebuck D; Brugieres L; Capra M; Brock P; Dall'Igna P; Otte JB; De Camargo B; Zsiros J; Zimmermann A; Aronson D; Childs M; Scopinaro M; Morland B; Plaschkes J; Czauderna P; Perilongo G
Eur J Cancer; 2012 Jul; 48(10):1543-9. PubMed ID: 22244829
[TBL] [Abstract][Full Text] [Related]
14. Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan.
Hsu WY; Chang HH; Lu MY; Yang YL; Jou ST; Chen HL; Ni YH; Hsu HY; Chang MH; Wu JF
Pediatr Neonatol; 2020 Aug; 61(4):393-398. PubMed ID: 32291200
[TBL] [Abstract][Full Text] [Related]
15. A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients.
Cairo S; Armengol C; Maibach R; Häberle B; Becker K; Carrillo-Reixach J; Guettier C; Vokuhl C; Schmid I; Buendia MA; Branchereau S; von Schweinitz D; Kappler R
Eur J Cancer; 2020 Dec; 141():30-39. PubMed ID: 33125945
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study.
Aronson DC; Schnater JM; Staalman CR; Weverling GJ; Plaschkes J; Perilongo G; Brown J; Phillips A; Otte JB; Czauderna P; MacKinlay G; Vos A
J Clin Oncol; 2005 Feb; 23(6):1245-52. PubMed ID: 15718322
[TBL] [Abstract][Full Text] [Related]
17. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.
Trobaugh-Lotrario A; Katzenstein HM; Ranganathan S; Lopez-Terrada D; Krailo MD; Piao J; Chung N; Randazzo J; Malogolowkin MH; Furman WL; McCarville EB; Towbin AJ; Tiao GM; Dunn SP; Langham MR; McGahren ED; Feusner J; Rodriguez-Galindo C; Meyers RL; O'Neill AF; Finegold MJ
J Clin Oncol; 2022 Feb; 40(5):459-467. PubMed ID: 34874751
[TBL] [Abstract][Full Text] [Related]
18. Is multifocality a prognostic factor in childhood hepatoblastoma?
Saettini F; Conter V; Provenzi M; Rota M; Giraldi E; Foglia C; Cavalleri L; D'Antiga L
Pediatr Blood Cancer; 2014 Sep; 61(9):1593-7. PubMed ID: 24757164
[TBL] [Abstract][Full Text] [Related]
19. Pure fetal histology subtype was associated with better prognosis of children with hepatoblastoma: A Chinese population-based study.
Qiao GL; Chen Z; Wang C; Ge J; Zhang Z; Li L; Ren J
J Gastroenterol Hepatol; 2016 Mar; 31(3):621-7. PubMed ID: 26401976
[TBL] [Abstract][Full Text] [Related]
20. Predictors of survival after resection of children with hepatoblastoma: A single Asian center experience.
Qiao GL; Li L; Cheng W; Ge J; Zhang Z; Wei Y
Eur J Surg Oncol; 2014 Nov; 40(11):1533-9. PubMed ID: 25103357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
